These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34982424)

  • 1. LINC00261 regulates EBF1 to suppress malignant progression of thyroid cancer.
    Fu XD; Liu CY; Liu YL; Su DW; Chi NN; Zhang JL; Wei WW
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7626-7634. PubMed ID: 34982424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
    Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
    Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
    J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
    Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
    Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0000144 facilitates the progression of thyroid cancer via the miR-217/AKT3 pathway.
    Fan YX; Shi HY; Hu YL; Jin XL
    J Gene Med; 2020 Dec; 22(12):e3269. PubMed ID: 32890417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of LINC00261 upregulation on the pancreatic cancer EMT process is mediated by KLF13 via the mTOR signaling pathway.
    Li B; Pang S; Dou J; Zhou C; Shen B; Zhou Y
    Clin Transl Oncol; 2022 Jun; 24(6):1059-1072. PubMed ID: 35066757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of long noncoding RNA DLX6-AS1 inhibits migration and invasion of thyroid cancer cells by upregulating UPF1.
    Zhong ZB; Wu YJ; Luo JN; Hu XN; Yuan ZN; Li G; Wang YW; Yao GD; Ge XF
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10867-10873. PubMed ID: 31858555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/FOXO3 axis.
    Chen T; Lei S; Zeng Z; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
    Oncol Rep; 2020 Mar; 43(3):930-942. PubMed ID: 32020223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
    Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-198 inhibits metastasis of thyroid cancer by targeting H3F3A.
    Fang J; Zhu JM; Dai HL; He LM; Kong L
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12232-12240. PubMed ID: 33336742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linc00261 suppresses growth and metastasis of non-small cell lung cancer via repressing epithelial-mesenchymal transition.
    Liao J; Dong LP
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3829-3837. PubMed ID: 31115010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
    Meng XF; Zhao LY; Chu XF
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of long intergenic noncoding RNA LINC00312 inhibits the invasion and migration of thyroid cancer cells by down-regulating microRNA-197-3p.
    Liu K; Huang W; Yan DQ; Luo Q; Min X
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28539331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA LINC00261 overexpression suppresses the growth and metastasis of lung cancer via regulating miR-1269a/FOXO1 axis.
    Guo C; Shi H; Shang Y; Zhang Y; Cui J; Yu H
    Cancer Cell Int; 2020; 20():275. PubMed ID: 32607060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
    Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and Clinical Significance of Long-chain Noncoding RNA LINC00261 in Colon Cancer.
    Zhou Z; Ma J
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGN5 promotes invasion and migration of colorectal cancer through activating FGF/FGFR pathway.
    Zhu GJ; Liu F; Xu YG; Zhao CX; Zhao JG; Sun C
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1330-1338. PubMed ID: 33629303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.